Skip to content

Optical Coherence Tomography - Guided Protocol for Left Main Percutaneous Coronary Intervention

LEft Main Oct Guided iNterventions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04248777
Acronym
LEMON
Enrollment
71
Registered
2020-01-30
Start date
2018-05-18
Completion date
2019-02-01
Last updated
2020-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Left Main Coronary Artery Stenosis

Keywords

Optical Coherence Tomography (OCT), Percutaneous Coronary Intervention (PCI).

Brief summary

LEMON aim is to evaluate the feasibility, efficiency and security of a standardized Optical Coherence Tomography (OCT) - guided protocol for completion and optimization of Left Main (LM) Percutaneous Coronary Intervention (PCI).

Detailed description

The LEMON study (LEft Main Oct-guided iNterventions) is a prospective, multicentre, open-label, interventional , non-randomized trial that investigates the feasibility and efficiency of OCT guidance for left main PCI in 10 active French interventional cardiology centres. The aim of the study is the appliance of a pre-defined standardized protocol for LM PCI . The LM PCI strategy is guided by 3 OCT runs, according to a pre-determined protocol. The first OCT run (run1) is performed before any stent implantation, the second run (run2) is performed after the stent is implanted, POT (proximal optimization technique) is applied and side branch iss rewired through stent struts. The third run (run3) is performed after PCI optimization. In case of additional stent optimization, a supplementary OCT run is applied in order to assess final result.

Interventions

OTHERstandardised OCT-guided intervention

The first OCT run (run1) analyse plaque characteristics, identify proximal and distal landing zones (according to previously published criteria) , measure lesion length and reference segments dimensions (diameters and luminal areas). The second run (run2) aims to assess adequate guidewire recrossing point into stent jailed side branch and identify early stent mechanical non-optimal results. The third run (run3) analyse final stent expansion and identify major struts malposition and edge dissection.

Sponsors

Institut Mutualiste Montsouris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Patients with left main artery planned PCI for stable or unstable coronary artery disease.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \>18 * stable or non-stable distal Left Main lesion (with or without previous Coronary Artery Bypass Graft), involving or not Left Anterior Descending and Coronary Circumflex ostias and requiring Percutaneous Coronary Intervention with a one or two stents strategy * stable or non-stable ostial Left Anterior Descending and/or Coronary Circumflex lesion requiring Percutaneous Coronary Intervention with involvement of distal Left Main * SYNTAX angiographic score \<23 * informed consent

Exclusion criteria

* ostial Left Main lesion * on-going acute STEMI * on-going cardiogenic shock * severe chronic renal failure (Cr Cl \<30 ml/min/m2) * anticipated technical contra-indication to OCT (highly calcified lesions, severe proximal tortuosity)

Design outcomes

Primary

MeasureTime frameDescription
success of the OCT procedurePost PCI / Immediatescore Thrombolysis In Myocardial Infarction (TIMI) equal to 3 in all vessels, 50% residual stenosis in the various angiography segments, adequate expansion according to minimum intra stent area \> 80% of the luminal area of the reference segment on Main Vessel and Main Branch.

Secondary

MeasureTime frameDescription
incidence of major adverse cardiovascular events30 days post PCIdeath, cardiovascular death, stent thrombosis, target vessel revascularization
rate of appropriate wire position30 days post PCIpercentage of appropriate wire position in adequate stent cell before side branch ostium dilation.
rate of appropriate stent expansion according to DOCTORS and ILUMIEN-III criteria.30 days post PCIpercentage of stent expansion according to DOCTORS and ILUMIEN-III

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026